[
  {
    "ts": null,
    "headline": "Stock Market Today: Dow Rises On Amazon, Apple Earnings; Nvidia, Palantir Rebound (Live Coverage)",
    "summary": "Stock Market Today: The Dow Jones index rose Friday as Amazon and Apple rallied on strong earnings results.",
    "url": "https://finnhub.io/api/news?id=6e7ee8cdd255ba12118e1eff9bd8b353748b8ed41a201ef5967b96fa9191bf82",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761913908,
      "headline": "Stock Market Today: Dow Rises On Amazon, Apple Earnings; Nvidia, Palantir Rebound (Live Coverage)",
      "id": 137277093,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Stock Market Today: The Dow Jones index rose Friday as Amazon and Apple rallied on strong earnings results.",
      "url": "https://finnhub.io/api/news?id=6e7ee8cdd255ba12118e1eff9bd8b353748b8ed41a201ef5967b96fa9191bf82"
    }
  },
  {
    "ts": null,
    "headline": "Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know",
    "summary": "Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
    "url": "https://finnhub.io/api/news?id=9e28e05610e1ff6bb8a9ec7c3099da36104a747eae8c17fcb92bef983209cc8e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761915603,
      "headline": "Investors Heavily Search Amgen Inc. (AMGN): Here is What You Need to Know",
      "id": 137279191,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen (AMGN) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.",
      "url": "https://finnhub.io/api/news?id=9e28e05610e1ff6bb8a9ec7c3099da36104a747eae8c17fcb92bef983209cc8e"
    }
  },
  {
    "ts": null,
    "headline": "AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025",
    "summary": "Amgen (NASDAQ:AMGN) today announced that new data from its cardiovascular portfolio, including late-breaking results from the Phase 3 VESALIUS-CV clinical trial of Repatha® (evolocumab), will be presented at the American Heart Association Scientific Sessions taking place November 7-10, 2025, in New Orleans, LA.",
    "url": "https://finnhub.io/api/news?id=9959dee8f8071eb7015b1f6ca3afbc5913501d633f056d4202af40f97dec2c25",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761915600,
      "headline": "AMGEN'S LANDMARK PHASE 3 REPATHA DATA TO BE PRESENTED AS LATE BREAKER AT THE AMERICAN HEART ASSOCIATION SCIENTIFIC SESSIONS 2025",
      "id": 137277396,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen (NASDAQ:AMGN) today announced that new data from its cardiovascular portfolio, including late-breaking results from the Phase 3 VESALIUS-CV clinical trial of Repatha® (evolocumab), will be presented at the American Heart Association Scientific Sessions taking place November 7-10, 2025, in New Orleans, LA.",
      "url": "https://finnhub.io/api/news?id=9959dee8f8071eb7015b1f6ca3afbc5913501d633f056d4202af40f97dec2c25"
    }
  },
  {
    "ts": null,
    "headline": "Amgen Stock: Analyst Estimates & Ratings",
    "summary": "Amgen stock has been underperforming the broader market over the past year, and analysts are adopting a cautiously bullish stance.",
    "url": "https://finnhub.io/api/news?id=9a17c53596ab70a02e6a00994fd5cf122bf3489be6f06acf37da83adbdb41a8e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761910678,
      "headline": "Amgen Stock: Analyst Estimates & Ratings",
      "id": 137279192,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen stock has been underperforming the broader market over the past year, and analysts are adopting a cautiously bullish stance.",
      "url": "https://finnhub.io/api/news?id=9a17c53596ab70a02e6a00994fd5cf122bf3489be6f06acf37da83adbdb41a8e"
    }
  },
  {
    "ts": null,
    "headline": "AbbVie: Why Q3 Confirms Its Immunology Dominance",
    "summary": "AbbVie posts strong Q3 results with $7.89B immunology sales, rising Elahere revenue, and Rinvoq Phase 3 success. Learn why ABBV stock is a strong buy.",
    "url": "https://finnhub.io/api/news?id=2cf08acf8bffde47895303fb70bac1b045d034f90b9bbef370a803bda96f3cba",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761907191,
      "headline": "AbbVie: Why Q3 Confirms Its Immunology Dominance",
      "id": 137277814,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/939034648/image_939034648.jpg?io=getty-c-w1536",
      "related": "AMGN",
      "source": "SeekingAlpha",
      "summary": "AbbVie posts strong Q3 results with $7.89B immunology sales, rising Elahere revenue, and Rinvoq Phase 3 success. Learn why ABBV stock is a strong buy.",
      "url": "https://finnhub.io/api/news?id=2cf08acf8bffde47895303fb70bac1b045d034f90b9bbef370a803bda96f3cba"
    }
  },
  {
    "ts": null,
    "headline": "CFOs On the Move: Week ending Oct. 31",
    "summary": "Agilent Technologies appoints a new finance chief, Fiserv shakes up its leadership and railroad operator CSX names a new CFO.",
    "url": "https://finnhub.io/api/news?id=4f5339e09da3ba110ddf1bcf68318b0bd049bbb1d01653c55e42d6dcf112de3c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1761904431,
      "headline": "CFOs On the Move: Week ending Oct. 31",
      "id": 137279193,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Agilent Technologies appoints a new finance chief, Fiserv shakes up its leadership and railroad operator CSX names a new CFO.",
      "url": "https://finnhub.io/api/news?id=4f5339e09da3ba110ddf1bcf68318b0bd049bbb1d01653c55e42d6dcf112de3c"
    }
  }
]